Cargando…

DNA-methylation subgroups carry no prognostic significance in ATRT-SHH patients in clinical trial cohorts

Detalles Bibliográficos
Autores principales:	Tran, Quynh T., Upadhyaya, Santhosh A., Billups, Catherine A., Onar-Thomas, Arzu, Alom, Md. Zahangir, Carey, Steven S., Robinson, Giles W., Ellison, David W., Gajjar, Amar, Orr, Brent A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2023
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10412479/ https://www.ncbi.nlm.nih.gov/pubmed/37522896 http://dx.doi.org/10.1007/s00401-023-02614-9

Ejemplares similares

ATRT-22. Outcomes for children with recurrent atypical teratoid rhabdoid tumor: A single institution study with updated molecular and germline analysis
por: Carey, Steven S, et al.
Publicado: (2022)

ATRT–SHH comprises three molecular subgroups with characteristic clinical and histopathological features and prognostic significance
por: Federico, Aniello, et al.
Publicado: (2022)

Imaging and multi-omics datasets converge to define different neural progenitor origins for ATRT-SHH subgroups
por: Lobón-Iglesias, María-Jesús, et al.
Publicado: (2023)

ATRT-27. COST-EFFECTIVE ASSAYS TO SUBGROUP ATRT IN THE DAILY ROUTINE
por: Lobon-Iglesias, María-Jesús, et al.
Publicado: (2020)

Comprehensive study of semi-supervised learning for DNA methylation-based supervised classification of central nervous system tumors
por: Tran, Quynh T., et al.
Publicado: (2022)

ATRT-28. SINGLE NUCLEI SEQUENCING REVEALS THE DIFFERENT PHENOTYPIC COMPOSITION OF THE ATRT SUBGROUPS
por: Johann, Pascal, et al.
Publicado: (2020)

ATRT-08. THE SINGLE-CELL LANDSCAPE OF PINEOBLASTOMA IDENTIFIES DEVELOPMENTAL ORIGINS AND EXPOSES TUMORIGENIC DEPENDENCIES
por: Gudenas, Brian, et al.
Publicado: (2023)

ATRT-13. An integrative analysis of the ATRT proteome unravels novel drug targets and refines molecular subgrouping
por: Johann, Pascal, et al.
Publicado: (2022)

Predicting methylation class from diffusely infiltrating adult gliomas using multimodality MRI data
por: Alom, Zahangir, et al.
Publicado: (2023)

ATRT-18. SHH-SUBTYPE ATYPICAL TERATOID/RHABDOID TUMORS ARE SELECTIVELY SENSITIVE TO GEMCITABINE TREATMENT
por: Metselaar, Dennis, et al.
Publicado: (2020)

Complete clinical regression of a BRAF V600E-mutant pediatric glioblastoma multiforme after BRAF inhibitor therapy
por: Robinson, Giles W, et al.
Publicado: (2014)

ATRT-11. Anatomico-biological correlations define a new layer for ATRT molecular subgroups pointing to potential lineages of origin
por: Lobon-Iglesias, Maria, et al.
Publicado: (2022)

ETMR-21. META-ANALYSIS OF PINEAL REGION TUMOURS DEMONSTRATES MOLECULAR SUBGROUPS WITH DISTINCT CLINICO-PATHOLOGICAL FEATURES: A CONSENSUS STUDY
por: Li, Bryan K, et al.
Publicado: (2020)

MEDB-69. Clinical and molecular meta-analysis of three major medulloblastoma clinical trials (ACNS0331, SJMB03, ACNS0332) uncovers novel strategies to improve risk-stratified therapy
por: Smith, Kyle S, et al.
Publicado: (2022)

TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma
por: Remke, Marc, et al.
Publicado: (2013)

ATRT-01. PARP INHIBITION AS A THERAPEUTIC TARGET IN ATRT
por: Alimova, Irina, et al.
Publicado: (2023)

ATRT-14. MACROPHAGE-TUMOR CELL INTERACTION PROMOTES ATRT PROGRESSION AND CHEMORESISTANCE
por: Melcher, Viktoria, et al.
Publicado: (2020)

ATRT-33. ENABLING RAPID CLASSIFICATION OF ATRT WITH NANOSTRING NCOUNTER PLATFORM
por: Ho, Ben, et al.
Publicado: (2020)

MBRS-24. FUNCTIONAL CHARACTERIZATION OF IKBKAP/ELP1 AS A NOVEL SHH MEDULLOBLASTOMA PREDISPOSITION GENE
por: Lopez, Jesus Garcia, et al.
Publicado: (2020)

SPCR-08 ACADEMIC READINESS AMONG CHILDREN TREATED FOR BRAIN TUMORS IN INFANCY
por: Silverman, Melanie, et al.
Publicado: (2023)

ATRT-12. LIN28A expression correlates with poor prognosis and the MYC subgroup in AT/RTs
por: Dottermusch, Matthias, et al.
Publicado: (2022)

ATRT-24. CELL SURFACE PROTEOME ANALYSIS OF ATRT IDENTIFIES TARGETS FOR IMMUNOTHERAPY
por: Cole, Allison, et al.
Publicado: (2020)

Macrophages in SHH subgroup medulloblastoma display dynamic heterogeneity that varies with treatment modality
por: Dang, Mai T., et al.
Publicado: (2021)

Macrophages in SHH subgroup medulloblastoma display dynamic heterogeneity that varies with treatment modality
por: Dang, Mai T., et al.
Publicado: (2023)

Cross-species epigenetics identifies a critical role for VAV1 in SHH subgroup medulloblastoma maintenance
por: Lindsey, Janet C., et al.
Publicado: (2014)

Sustained and durable response with Alisertib monotherapy in the treatment of relapsed Atypical Teratoid Rhabdoid Tumor (ATRT)
por: Howden, Kaitlyn, et al.
Publicado: (2022)

Irreversible growth plate fusions in children with medulloblastoma treated with a targeted hedgehog pathway inhibitor
por: Robinson, Giles W., et al.
Publicado: (2017)

ATRT-08. TARGETING THE TP53-MDM2 ENHANCES RADIATION SENSITIVITY IN ATRT
por: Alimova, Irina, et al.
Publicado: (2021)

Protein arginine methyltransferase 5 regulates SHH-subgroup medulloblastoma progression
por: Wynn, Daniel T, et al.
Publicado: (2022)

ATRT-25. INTEGRATED QUANTITATIVE SWATH-MS PROTEOMICS ANALYSIS OF ATRTs UNCOVERS NEW THERAPEUTIC OPPORTUNITIES
por: Finetti, Martina Anna, et al.
Publicado: (2020)

ATRT-05. REPURPOSED ANTI-MALARIAL QUINACRINE ACTIVATES P53 AND INHIBITS ATRT TUMORIGENICITY
por: Kaur, Harpreet, et al.
Publicado: (2021)

ATRT-31. SUCCESSFUL MULTIMODALITY MANAGEMENT OF ATRT OF THE LOWER DORSAL SPINE WITH SPINAL DROP METASTASIS
por: Biswas, Ahitagni, et al.
Publicado: (2020)

ATRT-15. LY6D – A CANDIDATE FOR NANOPARTICLE-BASED TARGETED THERAPIES OF ATRT
por: Hagemeier, Lea, et al.
Publicado: (2020)

ATRT-23. SIRT2 cooperates with SMARCB1 to induce a differentiation block in ATRT
por: Alimova, Irina, et al.
Publicado: (2022)

ATRT-05. DNA DAMAGE REPAIR INHIBITOR LP-184 INHIBITS CELL GROWTH IN ATRT
por: Kwon, Hyuk Jean, et al.
Publicado: (2023)

Medulloblastoma in China: Clinicopathologic Analyses of SHH, WNT, and Non-SHH/WNT Molecular Subgroups Reveal Different Therapeutic Responses to Adjuvant Chemotherapy
por: Zhang, Zhen-Yu, et al.
Publicado: (2014)

EPEN-54. ACNS0831, PHASE III RANDOMIZED TRIAL OF POST-RADIATION CHEMOTHERAPY IN PATIENTS WITH NEWLY DIAGNOSED EPENDYMOMA AGES 1 TO 21 YEARS
por: Smith, Amy, et al.
Publicado: (2020)

Outcome and molecular analysis of young children with choroid plexus carcinoma treated with non-myeloablative therapy: results from the SJYC07 trial
por: Liu, Anthony P Y, et al.
Publicado: (2020)

ATRT-16. MODELLING ATRT THROUGH SWI/SNF COMPLEX DEFICIENCY IN GENETICALLY-ENGINEERED MOUSE MODELS
por: Bondoc, Andrew, et al.
Publicado: (2020)

ATRT-19. Functional genomics reveal distinct modulators of response to CDK4/6 inhibitors in ATRTs
por: Merk, Daniel, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ulvqqfs5nf60q0im0gl37u3ugo